Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 3Lymphoma, Follicular 1Arthritis, Rheumatoid 1

Interventions

Methotrexate 8Adalimumab 7Etanercept 5tocilizumab 4Rituximab 4tofacitinib 3Abatacept 3olokizumab 2golimumab 2Tumor Necrosis Factor Inhibitors 2Antirheumatic Agents 2upadacitinib 1secukinumab 1sarilumab 1mavrilimumab 1baricitinib 1andecaliximab 1Vitamin D 1Vaccines 1TACI receptor-IgG Fc fragment fusion protein 1Syringes 1Sulfasalazine 1Saline Solution 1Leflunomide 1Hydroxychloroquine 1Herpes Zoster Vaccine 1Folic Acid 1Fish Oils 1Fatty Acids, Omega-3 1Eicosapentaenoic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all
NCT01374971 2014-04-08

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

Arthritis Treatment Center, Maryland

Phase 3 Completed
12 enrolled 4 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡